Debts
€450,820 81% of the balance sheet
Financial debts 83%Suppliers 2%Taxes and wages 1%Other 14%
Of this, €75,158 falls due within a year.
DNCL
Overview
Lifetime
6 annual accounts with figures on one time axispeak €73,207 (2024)
€36,151▼ 50.6%
lowest -€21,999 (2025)
-€21,999▼ €36,562
peak €124,870 (2024)
€102,872▼ 17.6%
€450,820▼ 2.3%
Board1 name since 2020
1 director
Documentsfilings and deeds
10-07-202621 days before the deadline
2025micro format
Gross margin from €73,207 to €36,151Loss of €21,999Equity from €124,870 to €102,872Cash from €19,730 to €8,002
Key points
from the 2025 annual accountsFilings
6 annual accounts 4 late
The 2022 accounts came latest: 57 days after the end of the period.
Position in the sector
-€21,999
Lower net result than 95% of companies in human health. Sector median €59,543 · 21,321 companies.
Checked score
Bankruptcy probability within 12 months
Financial strength
Score breakdown
Comparable companies, two years later
In July 2024, 748 companies had the same profile as DNCL has now. Each dot stands for 2 companies, two years later.
96.7%
were still trading
1.9%
stopped another way
1.3%
went bankrupt
Another 0.1% stopped without a precise date, possibly only after those two years.
Test of the method
The method was tested on the 497,762 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.
| Group | Expected | Actual |
|---|---|---|
| 1 | 0.2% | 0.2% |
| 2 | 0.3% | 0.5% |
| 3 | 0.5% | 0.6% |
| 4 | 0.7% | 0.8% |
| 5 | 0.9% | 0.9% |
| 6 | 1.3% | 1.5% |
| 7 | 1.6% | 1.8% |
| 8 | 1.8% | 1.8% |
| 9 | 2.9% | 3.1% |
| 10 | 5.6% | 6.1% |
A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.
This is an observation about 748 companies, not a prediction for DNCL. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.
Credit verdict
Credit check for an amount and term of your choice
Show the recommended maximum and see how the verdict changes with amount, term and advance.
The scores and ratios are Checked's own calculations, not a credit decision.
Signals
Board and ownership
Director, since 11-02-2020
- 226 sharesdeed of 13-02-2020
- 74 sharesdeed of 13-02-2020
Recent changes
Registered in the Peppol Directory
Reachable for e-invoices through 0208:0743549540
Registered office moved within Zwevegem
New registered office: Deerlijkstraat 139, 8550 Zwevegem · Previous registered office: Acacialaan 34, 8550 Zwevegem, België · Board meeting of 30-04-2024 · Gazette deed
Incorporation
Founders: and · 300 shares · Appointment: (director) · published on 13-02-2020 · Gazette deed
First establishment
Deerlijkstraat 139, Zwevegem
Comparable companies
same main activity, similar in size and age| Company | ||||
|---|---|---|---|---|
| DNCL Zwevegem | €553,692 | €36,151 | 18.6% | - |
| KOM & LEER Ostend | €517,162 | €45,933 | 11.6% | - |
| KINESITHERAPIE LISA COUCKE Kortrijk | €751,938 | €37,507 | 17.3% | - |
| Eline Daelemans Antwerp | €535,688 | €39,076 | 8.0% | - |
| VALANCO MEDICAL Schilde | €558,679 | €35,016 | 19.1% | - |
| GC Mechelen Mechelen | €647,405 | €34,166 | 0.2% | - |
| Podologie Claeys Lievegem | €396,023 | €39,029 | 6.6% | - |
These companies have the same main activity as DNCL: physiotherapy (NACE 86951). They are comparable in size and age: total assets between €396,000 and €752,000, founded between 2019 and 2021.
Official details
Source: KBO- Status
- Active since 11-02-2020Normal situation
- Activity
- PhysiotherapyNACE 86951and 1 other
- Establishment unit
- 2.300.694.3028550 Zwevegem, since 11-02-2020
- Financial year end
- 31 December
- Peppol
- Reachable since 01-12-2025
Annual accounts 2025
- €36,151▼ 50.6%
- ≈ €110,000estimated
- €21,999
- €102,872▼ 17.6%
- €553,692▼ 5.6%
- Filing
- Filed on 10-07-2026, 21 days before the end of the filing period
Insights on DNCL
DNCL files the micro format. That format states no turnover. The gross margin rose from €32,055 in 2020 to €36,151 in 2025.
Sources: KBO register, filings at the National Bank, Belgian Official Gazette.
Financials
Annual accounts 2025
micro format, filed on 10-07-2026, 21 days before the deadline€36,151
▼ 50.6%
€3,729
▼ 91.3%
-€21,999
▼ €36,562
-€45,114
▼ €19,377
18.6%
▼ 2.7 percentage points
0.40
▼ 0.17
Turnover and EBIT margin are not published. The micro format does not require them. The turnover shown is an estimate from the gross margin.
Turnover ≈ €110,000. Estimated: probably between €83,000 and €150,000.
Balance sheet
balance sheet total €553,692 on 31-12-2025What the company ownsHow it is paid for
in euro
in euro
Position in the sector
18.6%
Higher than 19% of 21,334 companies in 2025.
0.40
Lower than 95% of 20,884 companies in 2025.
-4.0%
Higher than 5% of 21,184 companies in 2025.
DNCL
Middle half of the sector
80% of the sector
Micro accounts in human health (NACE 86)
Net result: bottom quarter · Equity: middle half · Balance sheet total: middle half · Working capital: bottom quarter
Filed annual accounts
as filed with the National Bank, click a year to choose it| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| Balance sheet: assets | |||||||
20/58 |
553,692 | 586,232 | 142,492 | 108,370 | 74,219 | 43,163 | |
21/28 |
523,648 | 552,713 | 3,747 | 2,995 | - | 568 | |
22/27 |
523,648 | 552,713 | 3,747 | 2,995 | - | 568 | |
22 |
507,443 | 535,443 | - | - | - | - | |
23 |
2,014 | 2,531 | 3,747 | 2,995 | - | 568 | |
24 |
1,002 | - | - | - | - | - | |
26 |
13,189 | 14,739 | - | - | - | - | |
29/58 |
30,044 | 33,520 | 138,746 | 105,375 | 74,219 | 42,595 | |
40/41 |
20,540 | 12,583 | 111,660 | 25,645 | 17,289 | 2,519 | |
40 |
14,596 | 11,454 | 95,480 | 17,488 | 11,202 | 2,519 | |
41 |
5,944 | 1,129 | 16,180 | 8,158 | 6,086 | - | |
54/58 |
8,002 | 19,730 | 25,622 | 79,319 | 56,811 | 37,425 | |
490/1 |
1,502 | 1,207 | 1,464 | 411 | 119 | 2,651 | |
| Balance sheet: equity and liabilities | |||||||
10/49 |
553,692 | 586,232 | 142,492 | 108,370 | 74,219 | 43,163 | |
10/15 |
102,872 | 124,870 | 110,307 | 75,801 | 49,314 | 20,315 | |
10/11 |
300 | 300 | 300 | 300 | 300 | 300 | |
13 |
102,572 | 124,570 | 110,007 | 75,501 | 49,014 | 20,015 | |
133 |
102,572 | 124,570 | 110,007 | 75,501 | 49,014 | 20,015 | |
17/49 |
450,820 | 461,362 | 32,185 | 32,569 | 24,905 | 22,847 | |
17 |
375,662 | 402,105 | - | - | - | - | |
170/4 |
375,662 | 402,105 | - | - | - | - | |
42/48 |
75,158 | 59,257 | 20,730 | 25,909 | 22,716 | 20,873 | |
42 |
8,943 | 8,553 | - | - | - | - | |
44 |
6,881 | 0 | 2,636 | 2,929 | 1,964 | 2,219 | |
440/4 |
6,881 | 0 | 2,636 | 2,929 | 1,964 | 2,219 | |
45 |
5,789 | 10,514 | 18,093 | 22,981 | 20,752 | 6,642 | |
450/3 |
5,789 | 10,514 | 18,093 | 22,981 | 20,752 | 6,642 | |
47/48 |
53,545 | 40,190 | - | - | - | 12,012 | |
492/3 |
- | 0 | 11,455 | 6,659 | 2,189 | 1,974 | |
| Income statement | |||||||
9900 |
36,151 | 73,207 | 50,221 | 38,611 | 41,239 | 32,055 | |
630 |
30,080 | 26,533 | 1,026 | 273 | 568 | 568 | |
631/4 |
- | - | - | - | 466 | - | |
640/8 |
2,342 | 3,681 | 1,515 | 760 | 701 | 648 | |
9901 |
3,729 | 42,994 | 47,680 | 37,577 | 39,503 | 30,840 | |
75/76B |
19 | 0 | 4 | 23 | 16 | - | |
75 |
19 | 0 | 4 | 23 | 16 | - | |
65/66B |
25,562 | 23,060 | 1,853 | 749 | 595 | 230 | |
65 |
25,562 | 23,060 | 1,853 | 749 | 595 | 230 | |
9903 |
-21,814 | 19,934 | 45,831 | 36,852 | 38,924 | 30,610 | |
67/77 |
185 | 5,371 | 11,325 | 10,364 | 9,926 | 6,594 | |
9904 |
-21,999 | 14,563 | 34,506 | 26,487 | 28,999 | 24,015 | |
9905 |
-21,999 | 14,563 | 34,506 | 26,487 | 28,999 | 24,015 | |
| Appropriation of the result | |||||||
9906 |
-21,999 | 14,563 | 34,506 | 26,487 | 28,999 | 24,015 | |
791/2 |
21,999 | - | - | - | - | - | |
691/2 |
0 | 14,563 | 34,506 | 26,487 | 28,999 | 20,015 | |
6921 |
0 | 14,563 | 34,506 | 26,487 | 28,999 | 20,015 | |
694/7 |
- | - | - | - | - | 4,000 | |
695 |
- | - | - | - | - | 4,000 | |
| Document | |||||||
The notes to these accounts have 9 items, including the statement of assets and debts, the cost breakdown and rights and commitments. You find them in the accounts filed with the NBB.
Source: Annual accounts 2025 at the NBB, filed on 10-07-2026.
Filings
each dot is a set of accounts, on the day it reached the National Bank| Financial year | Type | Filed | Reference | Document |
|---|---|---|---|---|
| 31-12-2025 | micro format | 10-07-2026 | 2026-00277932 | |
| 31-12-2024 | micro format | 18-07-2025 | 2025-00312145 | |
| 31-12-2023 | micro format | 30-08-2024 | 2024-00456742 | |
| 31-12-2022 | micro format | 26-09-2023 | 2023-00469062 | |
| 31-12-2021 | micro format | 31-08-2022 | 2022-20420666 | |
| 31-12-2020 | micro format | 31-08-2021 | 2021-65800475 |
Key figures and ratios
per financial year, computed from the annual accounts| Line | Trend | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|---|---|
| 33,809 | 69,527 | 48,706 | 37,851 | 40,071 | 31,408 | ||
| 8,081 | 41,096 | 35,532 | 26,761 | 29,567 | 24,583 | ||
| 1,015 | 575,499 | 1,778 | 3,268 | 0 | 1,136 | ||
| -11,728 | -5,892 | -53,698 | 22,508 | 19,386 | - | ||
| -45,114 | -25,738 | 118,016 | 79,466 | 51,503 | 21,721 | ||
| 18.6% | 21.3% | 77.4% | 69.9% | 66.4% | 47.1% | ||
| 0.40 | 0.57 | 6.69 | 4.07 | 3.27 | 2.04 | ||
| 4.38 | 3.69 | 0.29 | 0.43 | 0.51 | 1.12 | ||
| -21.4% | 11.7% | 31.3% | 34.9% | 58.8% | 118.2% | ||
| -4.0% | 2.5% | 24.2% | 24.4% | 39.1% | 55.6% | ||
| 1.32 | 3.02 | 26.29 | 50.56 | 67.36 | - |
A Belgian filing has no cash-flow statement. Cash flow is therefore an approximation, derived from the income statement. Investment is the acquisitions in the notes and, without them, the balance-sheet move.
Securities and guarantees
on own assets and for others| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Mortgages, amount registered | €110,000 | €110,000 | - | - | - |
| Carrying value of the mortgaged assets | €507,443 | €535,443 | - | - | - |
Source: notes to the 2021 to 2025 annual accounts (statement of debts and off-balance-sheet rights and commitments)
Investments
fixed assets acquired| Item | 2025 | 2024 | 2023 | 2022 | 2021 |
|---|---|---|---|---|---|
| Tangible fixed assets | €1,015 | €575,499 | €1,778 | €3,268 | - |
| €30,080 | €26,533 | €1,026 | €273 | €568 |
Source: notes to the 2021 to 2025 annual accounts (statement of fixed assets)
Insights on DNCL
The operating result for 2025 is 91% lower than in 2024 and the lowest since 2020. It is the second fall in a row.
Debt's share of the balance-sheet total rises from 78.7% to 81.4%. Equity and debt are lower.
Board & ownership
Board
1 director, since incorporationDirector
since 11-02-2020
term for the life of the company
listed in the 2025 annual accounts, filed on 10-07-2026
- Signing authorityThe articles say who may bind the company, for example by signing a contract.
- Each director alonedeed of 13-02-2020
Mandates through the years
1 name, the dashed line is todayDirector
Board
Mandates as a list
-
- Director, from 11-02-2020 to date
Control
Founders
,
This company
DNCL
Equity €102,872
Loss €21,999 in 2025
Capital
- Contribution
- €300
- Shares
- 300
- Contribution per share
- €1
- Equity per share
- €343 in 2025
- Source
- 2025 annual accounts
Articles of association
deed of 13-02-2020 (in Dutch)- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimited
- Board ruleThese rules set how the board is made up, meets and takes decisions.
- 1 director
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 20:00
Shareholders
At incorporation
deed of 13-02-2020 ↗
- 226 shares (75.3%) · €226
- 74 shares (24.7%) · €74
Network & group
No group
DNCL has no parent and no holdings in its annual accounts. is the only director. DNCL shares no director with another company.
Timeline
Timeline
13 events since 2020Filings
Financial
Establishments
Address
2020202220242026
Deadline for the 2026 accounts: 31-07-2027
2026
Annual accounts 2025 filed NBBmicro format · 21 days before the deadline
2025
Weakest financial year net -€21,999 The net result drops to -€21,999, the lowest from 2020 to 2025.
Registered in the Peppol Directory Reachable for e-invoices through 0208:0743549540
Annual accounts 2024 filed PDFmicro format · 13 days before the deadline
2024
Registered office moved within ZwevegemNew registered office: Deerlijkstraat 139, 8550 Zwevegem · Previous registered office: Acacialaan 34, 8550 Zwevegem, België · Board meeting of 30-04-20242 points ▸
- Board meeting, 30-04-2024
- Registered-office move, Deerlijkstraat 139, 8550 Zwevegem
Annual accounts 2023 filed PDFmicro format · 30 days late
2023
Highest result from 2020 to 2025 net €34,506 ▲30.3% The operating result of €47,680 and the net result of €34,506 are both a record.
Equity above €100,000 equity €110,307 ▲45.5% With a profit in every financial year since 2020, equity grows to €110,307.
Annual accounts 2022 filed PDFmicro format · 57 days late
2022
Annual accounts 2021 filed PDFmicro format · 31 days late
2021
Annual accounts 2020 filed PDFmicro format · 31 days late
2020
IncorporationFounders: and · 300 shares · Appointment: (director) · published on 13-02-20204 points ▸
- Founder,
- Founder,
- 300 shares
- Director appointment,
- The deed holds 4 more points.
First establishment Deerlijkstraat 139, Zwevegem
Financial milestones sit on the financial year-end date, not the filing date.
Sources: Publications in the Belgian Official GazetteFilings with the National Bank
History
Company details
Identity
- Enterprise number
- 0743.549.540
- VAT number
- BE 0743.549.540
- Peppol ID
- 0208:0743549540
- Other Peppol ID
- 9925:BE0743549540
- Legal form
- Private limited company
- Status
- Active, normal situation
- Founded
- 11-02-2020
- Financial year
- ends on 31 December
- Annual meetingThe shareholders approve the annual accounts, among other things, at the annual meeting.
- First Saturday of June at 20:00deed of 13-02-2020 (in Dutch)
- Peppol
- Reachable since 01-12-2025Follow this company and you will hear the next morning if it leaves the Peppol register.
- Name
- DNCL in Dutch
- Entity type
- Legal entity
- DurationMost companies exist for an unlimited period, until they are dissolved.
- Unlimiteddeed of 13-02-2020 (in Dutch)
- Registered office clauseThe articles name the region of the registered office. The language of official documents depends on that region, among other things.
- “Acacialaan 34, 8550 Zwevegem”deed of 13-02-2020 (in Dutch)
Activities
NACEBEL 202586951
Physiotherapy main activity
Codes under NACEBEL 2008
86905
Human health activities main activity
82990
Other business support services
- PurposeThe purpose describes the activities the company may carry out under its articles.
- “Alle handelingen,werkzaamheden en activiteiten met betrekking tot osteopathie en kinesitherapie in al haar vormen,individueel en in groep…”deed of 13-02-2020 (in Dutch)
8 activities
- Alle handelingen,werkzaamheden en activiteiten met betrekking tot osteopathie en kinesitherapie in al haar vormen,individueel en in groep;
- Psychologische begeleiding en psychotherapie,individueel en in groep;alle activiteiten op het vlak van geestelijke gezondheidszorg;alle diensten en adviezen van psychologen en psychotherapeuten;
- Lichamelijke en mentale gezondheidspromotie,in de ruimste zin;
- Het patrimonium van de vennootschap beheren in de ruimste zin van het woord,en oordeelkundig uitbreiden,alle beschikbare middelen beleggen of wederbeleggen,zowel in roerende als in onroerende goederen,met uitsluiting van de handelingen van vastgoedhandelaar.
- Investeren in activa,dienstig voor eigen gebruik of ter verloning in natura van de bestuurders.
- Het toestaan van leningen en kredietopeningen aan vennootschappen of particulieren,onder om het even welke vorm;in dit kader kan zij zich ook borgstellen of haar aval verlenen,in de meest ruime zin,alle handels- en financiële operaties verrichten behalve die welke wettelijk voorbehouden zijn aan depositobanken,houders van deposito's op korte termijn,spaarkassen,hypotheekmaatschappijen en kapitalisatieondernemingen.
- Overgaan tot het aankopen,onderschrijven,beheren,verkopen,omruilen voor eigen rekening van aandelen en/of effecten allerlei van vennootschappen en/of verenigingen eender welke,alsmede van andere roerende en/of onroerende waarden,tegoeden en/of vorderingen;
- Overgaan tot het aankopen,verkopen,bouwen,verbouwen,opschikken,uitrusten,valoriseren,verhuren,onderverhuren,in huur nemen of leasen van onroerende goederen,al dan niet gemeubeld;
Registered office and establishments
1 establishment| Establishment | Start date | Unit number |
|---|---|---|
| Deerlijkstraat 139 registered office 8550 Zwevegem | 11-02-2020 | 2.300.694.302 |
Buildings and parcels at the address
- Ground area
- 1,123 m²
- Buildings
- 177 m²
- Volume, LiDAR
- 1,094 m³
- Tallest building
- 10.5 m
Buildings to scale, each on its own parcel
Parcels
| Cadastral parcel | Area | Buildings | Height / floors |
|---|---|---|---|
| 34042A0532/00L002 | 1,123 m² | 1 · 177 m² | 10.5 m · 2 |